Author

Tanuma Mistry

Observed name: T. Mistry

Institution: Chittaranjan National Cancer Institute

Observed institutions: University of Calcutta, Jadavpur University, Chittaranjan National Cancer Institute

ORCID: 0000-0001-5501-9903

Observed ORCID: 0000-0001-5501-9903

OpenAlex ID: A5076601665

Mitotic checkpoint defects: en route to cancer and drug resistance

2021 · Sinjini Sarkar, Pranab Kumar Sahoo, et al. · Chromosome Research · 55

Molecular targets and therapeutics in chemoresistance of triple-negative breast cancer

2021 · Arijit Nath, Soham Mitra, et al. · Medical Oncology · 44

PIM1/STAT3 axis: a potential co-targeted therapeutic approach in triple-negative breast cancer

2022 · Sutapa Mahata, Pranab K. Sahoo, et al. · Medical Oncology · 26

Assessment of quality of life among advanced ovarian cancer patients in a tertiary care hospital in India

2022 · Sinjini Sarkar, Pranab K. Sahoo, et al. · Supportive Care in Cancer · 16

Impact of Low BMI and Nutritional Status on Quality of Life and Disease Outcome in Breast Cancer Patients: Insights From a Tertiary Cancer Center in India

2024 · Tanuma Mistry, Ranita Pal, et al. · Nutrition and Cancer · 7

Premalignant and malignant lesions of oral cavity in eastern India: a hospital-based study

2020 · Pranab Kumar Sahoo, Sinjini Sarkar, et al. · European Journal of Cancer Prevention · 7

Emerging Futuristic Targeted Therapeutics: A Comprising Study Towards a New Era for the Management of TNBC

2023 · Tanuma Mistry, Arijit Nath, et al. · American Journal of Clinical Oncology · 5

Impact of low BMI and ABCC2 genotype on the clinical response of sequential anthracycline-taxane chemotherapy receiving breast cancer patients: a hospital-based study

2025 · Tanuma Mistry, Sanghamitra Sengupta, et al. · The Pharmacogenomics Journal · 3

Design and Synthesis of Propargyloxy Functionalized Pyrazole‐Based Aurones: Exploring Their Potent Anticancer Properties Against AGS and MCF‐7 Cell Lines

2024 · Ekta Lathwal, Suresh Kumar, et al. · Chemistry & Biodiversity · 3

PDF

Polymorphism of Transporter Genes Contributes to Variations in Treatment Outcomes and Adverse Events in Platinum Based- Chemotherapy- Treated Oral Cancer Patients

2024 · Pranab Kumar Sahoo, Tanuma Mistry, et al. · Precision Oncogenomics · 3

Outcomes of 3-year follow up with induction vs first line chemotherapy in oral cancer patients: An observational hospital-based study

2024 · Pranab Kumar Sahoo, Anup Kumar Bhowmick, et al. · Journal of Cancer Research and Therapeutics · 3

187P BUB1 (2530C>T) polymorphism and expression affects chemotherapy response and predicts poor prognosis in advanced epithelial ovarian cancer

2022 · S. Sarkar, P.K. Sahoo, et al. · Annals of Oncology · 3

Four Year Clinical Outcomes: Evaluating the Efficacy of Concomitant and Sequential Anthracycline-taxane Chemotherapy in Indian Breast Cancer Patients – A Regional Cancer Center Study

2024 · Tanuma Mistry, Partha Nath, et al. · Journal of Current Oncological Trends · 1

46P Predicting toxicity following cancer chemotherapy by detecting transporter gene ABCB1 (C1236T, G2677T/A, C3435CT) polymorphism in breast cancer patients receiving chemotherapy with anthracycline and taxane either sequentially or concomitantly

2023 · T. Mistry, R. Pal, et al. · Annals of Oncology · 1

Effect of overexpression of ERK1/2 and MDR1 on chemoresistance in advanced gastric cancer patients.

2023 · Sushmita Ghosh, Ranita Pal, et al. · Journal of Clinical Oncology · 1

CLO22-081: Clinical Efficacy and Quality of Life of Oral Cancer Patients Treated With Paclitaxel/Cisplatin/5-FU Vs Paclitaxel/Carboplatin Chemotherapeutic Regimens in a Tertiary Cancer Center in Eastern India

2022 · Pranab Kumar Sahoo, Sinjini Sarkar, et al. · Journal of the National Comprehensive Cancer Network · 1

Design, Synthesis, Cytotoxic Evaluation, and Multilevel Computational Studies of Novel Benzofuran-3-one Hybrids Bearing 1,2,3-Triazole and Pyrazole Scaffolds against AGS and MCF-7 Cancer Cells

2026 · Ekta Lathwal, Vikas Sharma, et al. · Journal of Molecular Structure

Pharmacogenomics of anthracycline-cyclophosphamide-taxane chemotherapy: an influence of CYP polymorphisms and BMI on breast cancer treatment outcomes

2025 · Tanuma Mistry, Partha Nath, et al. · Pharmacogenomics

Clinical implications of drug-metabolizing genes CYP3A4 and GSTP1 single nucleotide polymorphisms in oral cancer patients undergoing induction chemotherapy.

2023 · Pranab Kumar Sahoo, Tanuma Mistry, et al. · JCO Global Oncology

P-5 A soluble resistance related calcium binding protein (sorcin) up-regulates in the multi-drug resistant advanced gastric cancer patients

2023 · S. Ghosh, T. Mistry, et al. · Annals of Oncology

PDF

Single nucleotide polymorphisms of ABCB1 (rs1128503) and ABCC2 (rs145008610) genes and its clinical impact in ER & PR positive breast cancer patients in a tertiary care hospital of India

2022 · T. Mistry, S. Ghosh, et al. · European Journal of Cancer

Works count: 21

Citation count: 179

H-index: 6

I10-index: 4